NCT04197362

Brief Summary

This study aims to directly compare traditional everyday activity shoes (ASICS, Nike) with a shoe created to be flatter, less cushioned, and with less cradling of the foot (OESH shoe).

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 11, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 13, 2019

Completed
3.9 years until next milestone

Study Start

First participant enrolled

October 19, 2023

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 13, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 13, 2023

Completed
Last Updated

May 9, 2024

Status Verified

May 1, 2024

Enrollment Period

2 months

First QC Date

December 11, 2019

Last Update Submit

May 7, 2024

Conditions

Keywords

activity shoesforcestorquescartilagebones

Outcome Measures

Primary Outcomes (2)

  • Differences in torques at the knee comparing three study arms

    Joint torques and forces will be assessed via 16 markers placed on specified anatomical landmarks of the pelvis and lower extremities as the subjects walk across the gait floor at a self-selected speed. In analysis, joint torques and forces will be calculated through full inverse-dynamic model implementation using the Vicon Plug-In Gait. Differences in torques and peak forces will be calculated by ANOVA along with 95% confidence intervals.

    One-time at enrollment, no follow-up

  • Differences in forces at the knee comparing three study arms

    Joint torques and forces will be assessed via 16 markers placed on specified anatomical landmarks of the pelvis and lower extremities as the subjects walk across the gait floor at a self-selected speed. In analysis, joint torques and forces will be calculated through full inverse-dynamic model implementation using the Vicon Plug-In Gait. Differences in torques and peak forces will be calculated by ANOVA along with 95% confidence intervals.

    One-time at enrollment, no follow-up

Secondary Outcomes (12)

  • Differences in torques at the bilateral anterior and posterior superior spine comparing three study arms

    One-time at enrollment, no follow-up

  • Differences in forces at the bilateral anterior and posterior superior spine comparing three study arms

    One-time at enrollment, no follow-up

  • Differences in torques at the lateral femoral condyles comparing three study arms

    One-time at enrollment, no follow-up

  • Differences in forces at the lateral femoral condyles comparing three study arms

    One-time at enrollment, no follow-up

  • Differences in torques at the lateral mid-shanks comparing three study arms

    One-time at enrollment, no follow-up

  • +7 more secondary outcomes

Study Arms (3)

ASICS Women's Gel-Venture 6 Running-Shoe

EXPERIMENTAL

ASICS Women's Gel-Venture 6 Running-Shoe

Other: Evaluation

Nike Air Max 270

EXPERIMENTAL

Nike Air Max 270

Other: Evaluation

La Vida+

EXPERIMENTAL

La Vida+

Other: Evaluation

Interventions

Subjects will be asked to walk across the gait laboratory floor at their self-selected walking speed. They will complete a 3-5 minute warm up period, as it was found to produce stable estimates of kinetic parameter mean values during treadmill activity. The positions of each marker will be recorded through the motion capture system. Ground reaction force will be obtained in real time from the gait laboratory force plates as marker dimensions are recorded. For walking data, two trials of 15 seconds each will be recorded. The second trial will be a redundancy in the setting of potential significant marker dropout.

ASICS Women's Gel-Venture 6 Running-ShoeLa Vida+Nike Air Max 270

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsFemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Women between the ages of 18-65
  • Women who identify as "healthy"
  • Women who run or walk for exercise more than three times per week
  • Women in the Atlanta, Georgia area

You may not qualify if:

  • Individuals with history of significant musculoskeletal pathology
  • Individuals with musculoskeletal injury at time of testing
  • Individuals unable to consent
  • Individuals outside of the ages 18-65
  • Individuals who are prisoners
  • Individuals who do not speak or write in English

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Emory Rehabilitation Hospital

Atlanta, Georgia, 30322, United States

Location

Study Officials

  • David Burke, MD, MA

    Emory University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
CROSSOVER
Model Details: The subjects will be fitted in random order of a pair of ASICS Women's Gel-Venture 6 Running-Shoe, Nike Air Max 270, La Vida+ athletic shoes. Subjects will be pre-assigned randomly to start and continue with specific shoe groups, ultimately exhausting all options.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

December 11, 2019

First Posted

December 13, 2019

Study Start

October 19, 2023

Primary Completion

December 13, 2023

Study Completion

December 13, 2023

Last Updated

May 9, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be shared

Locations